For: | Al-Ameer AY, Al Nefaie S, Al Johani B, Anwar I, Al Tweigeri T, Tulbah A, Alshabanah M, Al Malik O. Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ. World J Clin Oncol 2016; 7(2): 258-264 [PMID: 27081649 DOI: 10.5306/wjco.v7.i2.258] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v7/i2/258.htm |
Number | Citing Articles |
1 |
Sijia Han, Fang Qiu, Ye Han, Yongqing Xu, Jianqiao Yin, Fei Xing, Xiaobo Bian, Guijin He. Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion. Journal of Applied Clinical Medical Physics 2021; 22(1): 293 doi: 10.1002/acm2.13122
|
2 |
Alison Price, Freya Schnabel, Jennifer Chun, Elianna Kaplowitz, Jenny Goodgal, Amber Guth, Deborah Axelrod, Richard Shapiro, Eralda Mema, Linda Moy, Farbod Darvishian, Daniel Roses. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS). The Breast Journal 2020; 26(5): 931 doi: 10.1111/tbj.13737
|
3 |
James W. Jakub, Brittany L. Murphy, Alexandra B. Gonzalez, Amy L. Conners, Tara L. Henrichsen, Santo Maimone, Michael G. Keeney, Sarah A. McLaughlin, Barbara A. Pockaj, Beiyun Chen, Tashinga Musonza, William S. Harmsen, Judy C. Boughey, Tina J. Hieken, Elizabeth B. Habermann, Harsh N. Shah, Amy C. Degnim. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease. Annals of Surgical Oncology 2017; 24(10): 2915 doi: 10.1245/s10434-017-5927-y
|
4 |
Ching-Wen Chiu, Li-Chieh Chang, Chih-Ming Su, Shen-Liang Shih, Ka-Wai Tam. Precise application of sentinel lymph node biopsy in patients with ductal carcinoma in situ: A systematic review and meta-analysis of real-world data. Surgical Oncology 2022; 45: 101880 doi: 10.1016/j.suronc.2022.101880
|
5 |
Serena Bertozzi, Carla Cedolini, Ambrogio P. Londero, Barbara Baita, Francesco Giacomuzzi, Decio Capobianco, Marta Tortelli, Alessandro Uzzau, Laura Mariuzzi, Andrea Risaliti. Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion. Medicine 2019; 98(1): e13831 doi: 10.1097/MD.0000000000013831
|
6 |
Jing Si, Rong Guo, Naisi Huang, Bingqiu Xiu, Qi Zhang, Weiru Chi, Jiong Wu. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy. Cancer Medicine 2019; 8(18): 7586 doi: 10.1002/cam4.2623
|
7 |
Sandra E Diaz Casas, Wilmar A Serrano Muñoz, Nelson A Buelvas Gómez, Ana M Osorio Ruiz, Javier Ángel Aristizábal, Luis H Guzmán Abisaab, Mauricio Garcia Mora, Carlos Lehmann Mosquera, Sergio Cervera-Bonilla, Ricardo Sanchez Pedraza. When is Sentinel Lymph Node Biopsy Useful in Ductal Carcinoma In Situ? The Experience at a Latin American Cancer Center. Cureus 2021; doi: 10.7759/cureus.16134
|
8 |
Hussain A Abdulla, Yasmeen Khalaf. De-escalation of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ. Cureus 2023; doi: 10.7759/cureus.37383
|
9 |
Eugene T Shin, Amy S Joehlin-Price, Doreen M Agnese, Debra L Zynger. Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ. American Journal of Clinical Pathology 2017; 148(5): 374 doi: 10.1093/ajcp/aqx089
|
10 |
Marjolaine Le Gac, Yohann Dabi, Anna Ilenko, Tiphaine De Foucher, Clément Ferrier, Sonia Zilberman, Julie Sussfeld, Cyril Touboul, Emile Daraï, Sofiane Bendifallah. Identification of patients with ductal carcinoma in situ at high risk of postoperative upstaging: A comprehensive review and an external (un)validation of predictive models developed. European Journal of Obstetrics & Gynecology and Reproductive Biology 2022; 271: 7 doi: 10.1016/j.ejogrb.2022.01.026
|